Literature DB >> 25741938

Early onset hearing loss in autosomal recessive hypophosphatemic rickets caused by loss of function mutation in ENPP1.

Elisabeth Steichen-Gersdorf, Bettina Lorenz-Depiereux, Tim Matthias Strom, Nicholas J Shaw.   

Abstract

Autosomal recessive hypophosphatemic rickets 2 (ARHR2) is a rare form of renal tubular phosphate wasting disorder. Loss of function mutations of the ecto-nucleotide pyrophosphatase/pyrophosphodiesterase 1 gene (ENPP1) causes a wide spectrum of phenotypes, ranging from lethal generalized arterial calcification of infancy to hypophosphatemic rickets with hypertension. Hearing loss was not previously thought to be one of the features of the disease entities and was merely regarded as a complication rather than a part of the disease. We report two children who presented in mid to late childhood with progressive varus deformity of their legs due to hypophosphatemic rickets caused by mutations in the ENPP1 gene. Both children had evidence of progressive hearing loss requiring the use of hearing aids. This report of two unrelated infants with compound heterozygous mutations in ENPP1 and previously published cases confirms that mild to moderate hearing loss is frequently associated with ARHR2. Early onset conductive hearing loss may further distinguish the autosomal recessive ENPP1 related type from other types of hypophosphatemia.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25741938     DOI: 10.1515/jpem-2014-0531

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  6 in total

Review 1.  Mutation update: Variants of the ENPP1 gene in pathologic calcification, hypophosphatemic rickets, and cutaneous hypopigmentation with punctate keratoderma.

Authors:  Douglas Ralph; Michael A Levine; Gabriele Richard; Michelle M Morrow; Elizabeth K Flynn; Jouni Uitto; Qiaoli Li
Journal:  Hum Mutat       Date:  2022-05-18       Impact factor: 4.700

Review 2.  New Therapies for Hypophosphatemia-Related to FGF23 Excess.

Authors:  Diana Athonvarangkul; Karl L Insogna
Journal:  Calcif Tissue Int       Date:  2020-06-05       Impact factor: 4.333

3.  Molecular Diagnoses of X-Linked and Other Genetic Hypophosphatemias: Results From a Sponsored Genetic Testing Program.

Authors:  Eric T Rush; Britt Johnson; Swaroop Aradhya; Daniel Beltran; Sara L Bristow; Scott Eisenbeis; Norma E Guerra; Stan Krolczyk; Nicole Miller; Ana Morales; Prameela Ramesan; Soodabeh Sarafrazi; Rebecca Truty; Kathryn Dahir
Journal:  J Bone Miner Res       Date:  2021-11-10       Impact factor: 6.390

Review 4.  Endocrine Glands and Hearing: Auditory Manifestations of Various Endocrine and Metabolic Conditions.

Authors:  Kripa Elizabeth Cherian; Nitin Kapoor; Suma Susan Mathews; Thomas Vizhalil Paul
Journal:  Indian J Endocrinol Metab       Date:  2017 May-Jun

5.  Improving the Pharmacodynamics and In Vivo Activity of ENPP1-Fc Through Protein and Glycosylation Engineering.

Authors:  Paul R Stabach; Kristin Zimmerman; Aaron Adame; Dillon Kavanagh; Christopher T Saeui; Christian Agatemor; Shawn Gray; Wenxiang Cao; Enrique M De La Cruz; Kevin J Yarema; Demetrios T Braddock
Journal:  Clin Transl Sci       Date:  2020-10-20       Impact factor: 4.689

Review 6.  Case Report and Review of Literature: Autosomal Recessive Hypophosphatemic Rickets Type 2 Caused by a Pathogenic Variant in ENPP1 Gene.

Authors:  Yunsoo Choe; Choong Ho Shin; Young Ah Lee; Man Jin Kim; Yun Jeong Lee
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-29       Impact factor: 6.055

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.